RELATIVE EXPRESSION OF CYTOCHROME P450 ISOENZYMES IN HUMAN LIVER AND ASSOCIATION WITH THE METABOLISM OF DRUGS AND XENOBIOTICS

被引:238
作者
FORRESTER, LM
HENDERSON, CJ
GLANCEY, MJ
BACK, DJ
PARK, BK
BALL, SE
KITTERINGHAM, NR
MCLAREN, AW
MILES, JS
SKETT, P
WOLF, CR
机构
[1] IMPERIAL CANC RES FUND,MOLEC PHARMACOL GRP,HUGH ROBSON BLDG,GEORGE SQ,EDINBURGH EH8 9XD,SCOTLAND
[2] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,LIVERPOOL L69 3BX,ENGLAND
[3] UNIV GLASGOW,DEPT PHARMACOL,GLASGOW G12 8QQ,SCOTLAND
关键词
D O I
10.1042/bj2810359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450s play a central role in the metabolism and disposition of an extremely wide range of drugs and chemical carcinogens. Individual differences in the expression of these enzymes may be an important determinant in susceptibility to adverse drug reactions, chemical toxins and mutagens. In this paper, we have measured the relative levels of expression of cytochrome P450 isoenzymes from eight gene families in a panel of twelve human liver samples in order to determine the individuality in their expression and whether any forms are co-regulated. Isoenzymes were identified in most cases on Western blots based on the mobility of authentic recombinant human cytochrome P450 standards. The levels of the following P450 proteins correlated with each other: CYP2A6, CYP2B6 and a protein from the CYP2C gene subfamily, CYP2E1 and a member of the CYP2A gene subfamily, CYP2C8, CYP3A3/A4 and total cytochrome P450 content. Also, the levels of two proteins in the CYP4A gene subfamily were highly correlated. These correlations are consistent with the relative regulation of members of these gene families in rats or mice. In addition, the level of expression of specific isoenzymes has also been compared with the rate of metabolism of a panel of drugs, carcinogens and model P450 substrates. These latter studies demonstrate and confirm that the correlations obtained in this manner represent a powerful approach towards the assignment of the metabolism of substrates by specific human P450 isoenzymes.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 78 条
  • [41] MOUSE-LIVER P450COH - GENETIC-REGULATION OF THE PYRAZOLE-INDUCIBLE ENZYME AND COMPARISON WITH OTHER P450-ISOENZYMES
    LANG, MA
    JUVONEN, R
    JARVINEN, P
    HONKAKOSKI, P
    RAUNIO, H
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 271 (01) : 139 - 148
  • [42] AMPLIFICATION AND INCREASED EXPRESSION OF ALPHA-CLASS GLUTATHIONE S-TRANSFERASE-ENCODING GENES ASSOCIATED WITH RESISTANCE TO NITROGEN MUSTARDS
    LEWIS, AD
    HICKSON, ID
    ROBSON, CN
    HARRIS, AL
    HAYES, JD
    GRIFFITHS, SA
    MANSON, MM
    HALL, AE
    MOSS, JE
    WOLF, CR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) : 8511 - 8515
  • [43] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [44] LU AYH, 1980, PHARMACOL REV, V31, P277
  • [45] MCMANUS ME, 1990, CANCER RES, V50, P3367
  • [46] MEEHAN RR, 1988, AM J HUM GENET, V42, P26
  • [47] REGULATION OF PHENOBARBITAL-INDUCIBLE CYTOCHROME-P-450S IN RAT AND MOUSE-LIVER FOLLOWING DEXAMETHASONE ADMINISTRATION AND HYPOPHYSECTOMY
    MEEHAN, RR
    FORRESTER, LM
    STEVENSON, K
    HASTIE, ND
    BUCHMANN, A
    KUNZ, HW
    WOLF, CR
    [J]. BIOCHEMICAL JOURNAL, 1988, 254 (03) : 789 - 797
  • [48] PATTERN OF SERUM-PROTEIN GENE-EXPRESSION IN MOUSE VISCERAL YOLK-SAC AND FETAL LIVER
    MEEHAN, RR
    BARLOW, DP
    HILL, RE
    HOGAN, BLM
    HASTIE, ND
    [J]. EMBO JOURNAL, 1984, 3 (08) : 1881 - 1885
  • [49] GENETIC-POLYMORPHISM OF HUMAN CYTOCHROME-P-450 (S)-MEPHENYTOIN 4-HYDROXYLASE - STUDIES WITH HUMAN AUTOANTIBODIES SUGGEST A FUNCTIONALLY ALTERED CYTOCHROME-P-450 ISOZYME AS CAUSE OF THE GENETIC DEFICIENCY
    MEIER, UT
    MEYER, UA
    [J]. BIOCHEMISTRY, 1987, 26 (25) : 8466 - 8474
  • [50] MEPHENYTOIN HYDROXYLATION POLYMORPHISM - CHARACTERIZATION OF THE ENZYMATIC DEFICIENCY IN LIVER-MICROSOMES OF POOR METABOLIZERS PHENOTYPED INVIVO
    MEIER, UT
    DAYER, P
    MALE, PJ
    KRONBACH, T
    MEYER, UA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) : 488 - 494